---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-125838"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2025-12-29T23:59:59+00:00"
generated_at: "2026-05-16T12:06:03.423769+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma receives Nasdaq extension until June 22, 2026 to regain minimum bid price compliance

## Summary
- Company failed to meet $1.00 minimum bid price requirement by initial Dec. 24, 2025 deadline.
- Nasdaq granted a 180-day extension, new compliance deadline is June 22, 2026.
- Common stock continues trading on The Nasdaq Capital Market under symbol SILO.
- If bid price closes at or above $1.00 for 10 consecutive business days, compliance will be achieved.
- Company may consider a reverse stock split during second compliance period if needed.

## SEC filing metadata
- accession: 0001213900-25-125838
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2025-12-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390025125838/0001213900-25-125838-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390025125838/ea0271073-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-125838
- JSON: https://secwatch.observer/filing/0001213900-25-125838.json
- Plain text: https://secwatch.observer/filing/0001213900-25-125838.txt

## Source-grounded claims
- claim_id: 70d5abccbe601025f63e5736881ed7ca3e1cfaa1
  claim: Silo Pharma, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  evidence_excerpt: June 27, 2025, the Company received a notification (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. The Company init
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514183/000121390025125838/0001213900-25-125838-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.